Predictors of pouch failure: A tertiary care inflammatory bowel disease centre experience

Abstract

AbstractAimRates of pouch failure after total proctocolectomy with ileal pouch−anal anastomosis (IPAA) range from 5% to 18%. There is little consistency across studies regarding the factors associated with failure, and most include patients who underwent IPAA in the pre‐biologic era. Our aim was to analyse a cohort of patients who underwent IPAA in the biologic era at a large‐volume inflammatory bowel disease institution to better determine preoperative, perioperative and postoperative factors associated with pouch failure.MethodsA retrospective cohort analysis was performed with data from an institutional review board approved prospective database with ulcerative colitis or unclassified inflammatory bowel disease patients who underwent total proctocolectomy with IPAA at Mount Sinai Hospital between 2008 and 2017. Preoperative, perioperative and postoperative data were collected and univariate and multivariate analyses were performed to identify factors associated with increased risk of pouch failure.ResultsOut of 664 patients included in the study, pouch failure occurred in 41 (6.2%) patients, a median of 23.3 months after final surgical stage. Of these, 17 (41.4%) underwent pouch excision and 24 (58.5%) had diverting ileostomies. The most common indications for pouch failure were Crohn's disease like pouch inflammation (CDLPI) (n = 17, 41.5%), chronic pouchitis (n = 6, 14.6%), chronic cuffitis (n = 5, 12.2%) and anastomotic stricture (n = 4, 9.8%). On multivariate analysis, pre‐colectomy biologic use (hazard ratio [HR] 2.25, 95% CI 1.09–4.67), CDLPI (HR 3.18, 95% CI 1.49–6.76) and pouch revision (HR 2.59, 95% CI 1.26–5.32) were significantly associated with pouch failure.ConclusionsPouch failure was significantly associated with CDLPI, preoperative biologic use and pouch revision; however, reassuringly it was not associated with postoperative complications.